Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1995; Volume 47,Issue 2
  • You have access
    Novel properties of homomeric beta 1 gamma-aminobutyric acid type A receptors: actions of the anesthetics propofol and pentobarbital.
    E Sanna, F Garau and R A Harris
    Molecular Pharmacology February 1995, 47 (2) 213-217;
  • You have access
    Multiple regions of G alpha 16 contribute to the specificity of activation by the C5a receptor.
    C H Lee, A Katz and M I Simon
    Molecular Pharmacology February 1995, 47 (2) 218-223;
  • You have access
    Agonist-dependent phosphorylation of human muscarinic receptors in Spodoptera frugiperda insect cell membranes by G protein-coupled receptor kinases.
    S K Debburman, P Kunapuli, J L Benovic and M M Hosey
    Molecular Pharmacology February 1995, 47 (2) 224-233;
  • You have access
    The class III antiarrhythmic drug amiodarone directly activates pertussis toxin-sensitive G proteins.
    A Hagelüken, B Nürnberg, R Harhammer, L Grünbaum, W Schunack and R Seifert
    Molecular Pharmacology February 1995, 47 (2) 234-240;
  • You have access
    Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance.
    C D Smith, J T Zilfou, K Stratmann, G M Patterson and R E Moore
    Molecular Pharmacology February 1995, 47 (2) 241-247;
  • You have access
    Activation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons.
    G M Yan, S Z Lin, R P Irwin and S M Paul
    Molecular Pharmacology February 1995, 47 (2) 248-257;
  • You have access
    Differential regulation by anti-tumor-promoting 12-deoxyphorbol-13-phenylacetate reveals distinct roles of the classical and novel protein kinase C isozymes in biological responses of primary mouse keratinocytes.
    Z Szallasi, K Kosa, C B Smith, A A Dlugosz, E K Williams, S H Yuspa and P M Blumberg
    Molecular Pharmacology February 1995, 47 (2) 258-265;
  • You have access
    Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy-vitamin D3.
    P Nambi, H L Wu, D Lipshutz and U Prabhakar
    Molecular Pharmacology February 1995, 47 (2) 266-271;
  • You have access
    Differential in vivo induction of immediate early genes by oxotremorine in the central nervous system of long- and short-sleep mice.
    L Tsiokas and M Watson
    Molecular Pharmacology February 1995, 47 (2) 272-282;
  • You have access
    Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor.
    E R Korpi, T Kuner, P H Seeburg and H Lüddens
    Molecular Pharmacology February 1995, 47 (2) 283-289;
  • You have access
    In vitro transcription termination by N,N'-bis(2-chloroethyl)-N-nitrosourea-induced DNA lesions.
    R O Pieper, S L Noftz and L C Erickson
    Molecular Pharmacology February 1995, 47 (2) 290-295;
  • You have access
    Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells.
    J J Stegeman, M E Hahn, R Weisbrod, B R Woodin, J S Joy, S Najibi and R A Cohen
    Molecular Pharmacology February 1995, 47 (2) 296-306;
  • You have access
    Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine.
    D R Luthin, R A Olsson, R D Thompson, D R Sawmiller and J Linden
    Molecular Pharmacology February 1995, 47 (2) 307-313;
  • You have access
    Molecular determinants of the species selectivity of neurokinin type 1 receptor antagonists.
    L Pradier, E Habert-Ortoli, L Emile, J Le Guern, I Loquet, M D Bock, J Clot, L Mercken, V Fardin and C Garret
    Molecular Pharmacology February 1995, 47 (2) 314-321;
  • You have access
    Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes.
    R P Xiao, X Ji and E G Lakatta
    Molecular Pharmacology February 1995, 47 (2) 322-329;
  • You have access
    Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains.
    J Beltman, D E Becker, E Butt, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo
    Molecular Pharmacology February 1995, 47 (2) 330-339;
  • You have access
    Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins.
    E Butt, J Beltman, D E Becker, G S Jensen, S D Rybalkin, B Jastorff and J A Beavo
    Molecular Pharmacology February 1995, 47 (2) 340-347;
  • You have access
    Characterization of presynaptic calcium channels with omega-conotoxin MVIIC and omega-grammotoxin SIA: role for a resistant calcium channel type in neurosecretion.
    T J Turner, R A Lampe and K Dunlap
    Molecular Pharmacology February 1995, 47 (2) 348-353;
  • You have access
    Selective actions of certain neuroactive pregnanediols at the gamma-aminobutyric acid type A receptor complex in rat brain.
    L D McCauley, V Liu, J S Chen, J E Hawkinson, N C Lan and K W Gee
    Molecular Pharmacology February 1995, 47 (2) 354-362;
  • You have access
    Different subunit requirements for volatile and nonvolatile anesthetics at gamma-aminobutyric acid type A receptors.
    B D Harris, G Wong, E J Moody and P Skolnick
    Molecular Pharmacology February 1995, 47 (2) 363-367;
  • You have access
    Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    C Pifl, H Drobny, H Reither, O Hornykiewicz and E A Singer
    Molecular Pharmacology February 1995, 47 (2) 368-373;
  • You have access
    Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.
    K A Wafford, M Kathoria, C J Bain, G Marshall, B Le Bourdellès, J A Kemp and P J Whiting
    Molecular Pharmacology February 1995, 47 (2) 374-380;
  • You have access
    Time- and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid.
    J S Poling, J W Karanian, N Salem and S Vicini
    Molecular Pharmacology February 1995, 47 (2) 381-390;
  • You have access
    A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
    B L Robbins, M C Connelly, D R Marshall, R V Srinivas and A Fridland
    Molecular Pharmacology February 1995, 47 (2) 391-397;
  • You have access
    Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
    M J Rogers, X Xiong, R J Brown, D J Watts, R G Russell, A V Bayless and F H Ebetino
    Molecular Pharmacology February 1995, 47 (2) 398-402;
  • You have access
    Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    A Tsafack, J Golenser, J Libman, A Shanzer and Z I Cabantchik
    Molecular Pharmacology February 1995, 47 (2) 403-409;
  • You have access
    Oxidative metabolism of lansoprazole by human liver cytochromes P450.
    L Pichard, R Curi-Pedrosa, C Bonfils, E Jacqz-Aigrain, J Domergue, H Joyeux, J Cosme, F P Guengerich and P Maurel
    Molecular Pharmacology February 1995, 47 (2) 410-418;
  • You have access
    Interaction of flavones and their bromoacetyl derivatives with NAD(P)H:quinone acceptor oxidoreductase.
    S Chen, P S Deng, K Swiderek, M Li and S I Chan
    Molecular Pharmacology February 1995, 47 (2) 419-424;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 47, Issue 2
1 Feb 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics